MedTrace Logo

DYG Versus Cetrorelix in Oocyte Donation

NCT05577806 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 202

Last updated 2022-10-13

No results posted yet for this study

Summary

Prospective controlled study to assess the reproductive outcomes of OD recipients in which the donors were subjected to the DYG protocol (20mg/day) compared with those subjected to the short protocol with cetrorelix (0.25 mg/day) from Day 7 or since a leading follicle reached 14 mm. The OD cycles were triggered with triptoreline acetate and the trigger criterion was ≥3 follicles of diameter \>18mm.

Conditions

  • Infertility, Female
  • Fertility Disorders

Interventions

DRUG

Dydrogesterone

progestin primed ovarian stimulation

Sponsors & Collaborators

  • Clinica de la Mujer Medicina Reproductiva, Chile

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05577806 on ClinicalTrials.gov